View in EDS HTML Full Text PDF Full Text

CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.

Saved in:
Bibliographic Details
Title: CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.
Authors: Lazaar, Aili L.1 (AUTHOR) aili.l.lazaar@gsk.com, Miller, Bruce E.1 (AUTHOR), Donald, Alison C.1 (AUTHOR), Keeley, Thomas2 (AUTHOR), Ambery, Claire2 (AUTHOR), Russell, John1 (AUTHOR), Watz, Henrik3 (AUTHOR), Tal-Singer, Ruth1 (AUTHOR), for 205724 Investigators (AUTHOR), Bardin, Philip (AUTHOR), Bremner, Peter (AUTHOR), Langton, David (AUTHOR), Southcott, Anne-Marie (AUTHOR), Thomas, Paul S. (AUTHOR), Wheatley, John (AUTHOR), Chapman, Kenneth R. (AUTHOR), Ferguson, Murdo (AUTHOR), Homik, Lawrence A. (AUTHOR), Maltais, Francois (AUTHOR), Pek, Bonavuth (AUTHOR)
Source: Respiratory Research. 6/12/2020, Vol. 21 Issue 1, p1-10. 10p. 1 Diagram, 5 Charts, 1 Graph.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14659921
DOI:10.1186/s12931-020-01401-4